100% Quality Guarantee
PhD-Level Technical Support
Human BCL2L14(Apoptosis facilitator Bcl-2-like protein 14) ELISA Kit
Key Features

Human BCL2L14 (Apoptosis facilitator Bcl-2-like protein 14) ELISA Kit (AEFI00167)

SKU AEFI00167
Product Type ELISA Kit
Size 48T/96T
Reactivity Human
Detection Method Sandwich ELISA, Double Antibody
Sensitivity 9.375 pg/mL
Range 15.625-1000 pg/mL
€649 - €5,841

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

Human BCL2L14 (Apoptosis facilitator Bcl-2-like protein 14) ELISA Kit

The Human BCL2L14 (Apoptosis Facilitator BCL-2-like Protein 14) ELISA Kit is specifically designed for the accurate measurement of BCL2L14 levels in human serum, plasma, and cell culture supernatants. This kit offers high sensitivity and specificity, ensuring trustworthy and consistent results for various research applications. BCL2L14 is a key protein involved in apoptosis regulation, playing a crucial role in programmed cell death pathways. Dysregulation of BCL2L14 has been linked to various diseases, including cancer, autoimmune disorders, and neurodegenerative conditions, highlighting its significance as a biomarker for understanding these diseases and exploring potential therapeutic interventions.

With its reliable performance and versatility, the Human BCL2L14 ELISA Kit is an essential tool for researchers investigating apoptosis mechanisms and developing targeted therapies for diseases associated with BCL2L14 dysregulation.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose